FGF21 and coronary artery disorder: However, by strictly matching body mass indices, serum FGF21 levels correlate in patients with metabolic disorders, but not CAD, indicating that this relationship is attributed more to preexisting cardio-metabolic factors than CAD per se (Lee et al., 2014; Domouzoglou et al., 2015).